Stock Screener App

Frei -

Installieren

1.68

2.89% -0.05

after-market

Handel nachbörslich: 1.70 0.02 +1.19%

In 8 Bio Inc (INAB)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

In 8 Bio Inc Aktie (INAB) Neueste Nachrichten

GRI Bio (NASDAQ: GRI) closes $8.0M offering of 10,666,667 shares, warrants - Stock Titan

GRI Bio (NASDAQ: GRI) prices $8,000,000 offering of 10,666,667 shares at $0.75 - Stock Titan

Inmune Bio Ends Sales Agreement with RBC and BTIG - TipRanks

GRI Bio, Inc. Announces Positive Phase 2a Trial Results for GRI-0621 - TradingView

GRI Bio (NASDAQ: GRI) unveils Phase 2a IPF results showing favorable safety and collagen biomarker shifts - Stock Titan

GRI Bio Reports Positive Phase 2a Trial Results for IPF Treatment - TradingView

The 4 billion won investment quietly implemented by Yuhan four years ago returned to a "large jackpo.. - 매일경제

Pres Kalowski Sells 9,072 ($31.4K) Of Q32 Bio Inc [QTTB] - TradingView

CEO Morrison Sells 22,506 ($77.9K) Of Q32 Bio Inc [QTTB] - TradingView

Nuvation Bio (NUVB) Chief Medical Officer reports 150K share sale and option exercise - Stock Titan

Upstream Bio (NASDAQ:UPB) Shares Down 8%Here's What Happened - MarketBeat

INMB SEC FilingsInmune Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Climb Bio, Inc. (CLYM) Stock Price, News, Quote & History - Yahoo! Finance Canada

Risk Off: Will Passage Bio Inc. stock sustain high P E ratiosQuarterly Portfolio Report & Free Technical Confirmation Trade Alerts - moha.gov.vn

Officer Liu Files To Sell 10,000 Of Nuvation Bio Inc [NUVB] - TradingView

KALA BIO Form 3 shows CEO and director hold no KALA stock - Stock Titan

Can Korro Bio Inc. stock surprise with earnings upsideWeekly Profit Summary & Growth Focused Stock Pick Reports - BỘ NỘI VỤ

Nuvation Bio Inc Discontinues NUV-1511 Development - TradingView

Nuvation Bio to Participate in Upcoming Investor Conferences - Business Wire

Chmn Hoffman Buys 39,200 ($159.9K) Of Annovis Bio Inc [ANVS]-Amended - TradingView

KALA BIO, Inc. Announces Executive and Board Changes - TradingView

[8-K] KALA BIO, Inc. Reports Material Event | KALA SEC FilingForm 8-K - Stock Titan

Chmn Hoffman Buys 39,200 ($159.9K) Of Annovis Bio Inc [ANVS] - TradingView

Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewswire

Officer Hattersley Sells 369,051 ($2.7M) Of Nuvation Bio Inc [NUVB] - TradingView

Chmn Hoffman Buys 20,000 ($69.9K) Of Annovis Bio Inc [ANVS] - TradingView

Officer Hanley Sells 200,000 ($1.4M) Of Nuvation Bio Inc [NUVB] - TradingView

Officer Hattersley Files To Sell 369,051 Of Nuvation Bio Inc [NUVB] - TradingView

Officer Liu Files To Sell 20,000 Of Nuvation Bio Inc [NUVB] - TradingView

Nuvation Bio Surges On Ibtrozi Momentum And B. Riley Buy Rating (NYSE:NUVB) - Seeking Alpha

Officer Liu Sells 30,000 ($148K) Of Nuvation Bio Inc [NUVB] - TradingView

TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewswire

[Form 4] Inmune Bio, Inc. Insider Trading Activity - Stock Titan

[8-K] Inmune Bio, Inc. Reports Material Event | INMB SEC FilingForm 8-K - Stock Titan

Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference - Yahoo Finance

Nuvation Bio Inc Publishes Positive Phase 2 Study Results for Safusidenib - TradingView

Adicet Bio special meeting to vote on flexible reverse stock split - Stock Titan

[8-K] TELA Bio, Inc. Reports Material Event | TELA SEC FilingForm 8-K - Stock Titan

Korro Bio, Inc. (KRRO): RBC Capital Initiates “Sector Perform” Rating with Upside Potential - Stocks Telegraph

[8-K] Instil Bio, Inc. Reports Material Event | TIL SEC FilingForm 8-K - Stock Titan

[8-K] Annovis Bio, Inc. Reports Material Event | ANVS SEC FilingForm 8-K - Stock Titan

[S-8] PALISADE BIO, INC. Employee Benefit Plan Registration | PALI SEC FilingForm S-8 - Stock Titan

[Form 4] Annovis Bio, Inc. Insider Trading Activity - Stock Titan

Inmune Bio, Inc. Announces Key Developments in Clinical Programs - TradingView

[8-K] Passage BIO, Inc. Reports Material Event | PASG SEC FilingForm 8-K - Stock Titan

[8-K] Cabaletta Bio, Inc. Reports Material Event | CABA SEC FilingForm 8-K - Stock Titan

Belite Bio Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView

KALA BIO Inc expected to post a loss of $1.45 a shareEarnings Preview - TradingView

IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewswire Inc.

[8-K] Climb Bio, Inc. Reports Material Event | CLYM SEC FilingForm 8-K - Stock Titan

Climb Bio, Inc. SEC 10-Q Report - TradingView

[8-K] Gossamer Bio, Inc. Reports Material Event | GOSS SEC FilingForm 8-K - Stock Titan

Gossamer Bio Inc reports results for the quarter ended September 30Earnings Summary - TradingView

[PRE 14A] Adicet Bio, Inc. Preliminary Proxy Statement - Stock Titan

[8-K] Adicet Bio, Inc. Reports Material Event | ACET SEC FilingForm 8-K - Stock Titan

[8-K] ImmunityBio, Inc. Reports Material Event | IBRX SEC FilingForm 8-K - Stock Titan

TELA Bio to Announce Third Quarter 2025 Financial Results - GlobeNewswire

Cabaletta Bio (Nasdaq: CABA) offers webcasts across Nov–Dec conferences; 30-day replays - Stock Titan

Gossamer Bio Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView

[Form 4] TELA Bio, Inc. Insider Trading Activity - Stock Titan

[Form 3] TELA Bio, Inc. Initial Statement of Beneficial Ownership - Stock Titan

Nuvation Bio Inc. SEC 10-Q Report - TradingView

Cabaletta Bio, Inc. (NASDAQ:CABA) Short Interest Up 85.8% in October - Defense World

[8-K] Protagenic Therapeutics, Inc.new Reports Material Event | PTIX SEC FilingForm 8-K - Stock Titan

Adicet Bio (Nasdaq: ACET) grants options for 97,200 shares and four-year vesting - Stock Titan

RPRX

$38.39

1.08%

INCY

$95.41

0.72%

GMAB

$31.31

3.07%

BNTX

$94.81

1.24%

ONC

$319.06

0.55%

INSM

$197.01

0.91%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters